ZBH
Zimmer Biomet Holdings, Inc. · Healthcare · Medical - Devices
Input momentum (manajer yang sebanding):
keluasan pemegang +17.6% ·
aliran saham +0.3% ·
posisi baru bersih +15.0%
— formula
Akumulasi luas — peningkatan saham di lebih banyak pemegang
Semua angka kepemilikan: hanya manajer 13F yang dipantau, posisi saham biasa, periode pelaporan Q1 2025
| Kuartal | Pemegang | Δ | Saham | Nilai yang dilaporkan | Baru | Keluar |
|---|---|---|---|---|---|---|
| Q2 2026 | 158 | +1 | 160.28M | $13.80B | +8 | −6 |
| Q1 2026 | 159 | -2 | 157.26M | $14.21B | +8 | −11 |
| Q4 2025 | 160 | -1 | 174.74M | $15.72B | +3 | −3 |
| Q3 2025 | 25 | +3 | 107.43M | $10.58B | +3 | −1 |
| Q2 2025 | 20 | -3 | 103.64M | $9.45B | +2 | −5 |
| Q1 2025 | 20 | +3 | 59.00M | $6.68B | +3 | — |
| Q4 2024 | 17 | 0 | 58.85M | $6.22B | +1 | −1 |
| Q3 2024 | 16 | -2 | 46.04M | $4.97B | — | −2 |
| Q2 2024 | 18 | — | 44.34M | $4.81B | — | — |
| # | Manajer | Saham | Δ saham | Nilai | Bobotnya | Dipegang | ||
|---|---|---|---|---|---|---|---|---|
| 1 | Dodge & Cox ✦ | 19.56M | +2.3% | $2.21B | 1.3% | ▲ Add | 4 | SEC ↗ |
| 2 | T. Rowe Price ✦ | 14.46M | -2.1% | $1.64B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 3 | T. Rowe Price ✦ | 14.46M | -2.1% | $1.64B | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 4 | State Street Global Advisors ✦ (pasif) | 8.75M | -2.5% | $992.92M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | Geode Capital Management ✦ (pasif) | 5.06M | +3.6% | $570.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 6 | Geode Capital Management ✦ (pasif) | 5.06M | +3.6% | $570.36M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 7 | PRIMECAP Management ✦ | 4.68M | -2.4% | $530.02M | 0.4% | ▼ Trim | 4 | SEC ↗ |
| 8 | Norges Bank ✦ (pasif) | 2.13M | +3.9% | $240.68M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 9 | Citadel Advisors ✦ | 2.04M | -15.1% | $231.18M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 10 | Millennium Management ✦ | 676.11K | +378.4% | $76.52M | 0.1% | ▲ Add | 4 | SEC ↗ |
| 11 | Arrowstreet Capital ✦ | 472.72K | +2.8% | $53.50M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 12 | Marshall Wace ✦ | 347.85K | Baru | $39.37M | 0.1% | New | 1 | SEC ↗ |
| 13 | Marshall Wace ✦ | 347.85K | Baru | $39.37M | 0.1% | New | 1 | SEC ↗ |
| 14 | Marshall Wace ✦ | 347.85K | Baru | $39.37M | 0.1% | New | 1 | SEC ↗ |
| 15 | AQR Capital Management ✦ | 345.31K | -18.3% | $38.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 16 | AQR Capital Management ✦ | 345.31K | -18.3% | $38.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 17 | AQR Capital Management ✦ | 345.31K | -18.3% | $38.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 18 | AQR Capital Management ✦ | 345.31K | -18.3% | $38.76M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 19 | GAMCO Investors ✦ | 200.79K | -3.6% | $22.73M | 0.2% | ▼ Trim | 4 | SEC ↗ |
| 20 | Point72 Asset Management ✦ | 87.83K | Baru | $9.94M | 0.0% | New | 1 | SEC ↗ |
| 21 | D. E. Shaw & Co. ✦ | 46.23K | -85.4% | $5.23M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 22 | Adage Capital Partners ✦ | 37.24K | Baru | $4.21M | 0.0% | New | 1 | SEC ↗ |
| 23 | Wellington Management ✦ | 36.87K | +230.6% | $4.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 24 | Wellington Management ✦ | 36.87K | +230.6% | $4.17M | 0.0% | ▲ Add | 4 | SEC ↗ |
| 25 | Two Sigma Investments ✦ | 30.40K | -21.4% | $3.44M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 26 | Gotham Asset Management ✦ | 22.14K | -56.4% | $2.51M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 27 | Bridgewater Associates ✦ | 8.52K | -95.8% | $964,407 | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 28 | Fisher Asset Management ✦ | 4.57K | -12.9% | $517,256 | 0.0% | ▼ Trim | 4 | SEC ↗ |
"Bobot mereka" = porsi posisi dari total nilai ekuitas 13F yang dilaporkan manajer tersebut — ukuran keyakinan. ✦ = manajer yang dikurasi.
Pembeli baru
| Marshall Wace | $39.37M | 0.1% |
| Marshall Wace | $39.37M | 0.1% |
| Marshall Wace | $39.37M | 0.1% |
| Point72 Asset Management | $9.94M | 0.0% |
| Adage Capital Partners | $4.21M | 0.0% |
Telah keluar
| Tidak ada keluar yang terlacak kuartal ini. |
Konteks pasar penuh: di SEMUA filer 13F (data terstruktur SEC, Q1 2026): 908 pemegang, 191.49M saham, $15.84B dilaporkan. Ini adalah periode berbeda yang lebih lama dibandingkan angka semesta yang dilacak di atas, dan keduanya tidak pernah dicampur.
Apa lagi yang paling sering dimiliki oleh pemegang efek ini yang dilacak — berdasarkan jumlah kepemilikan bersama, bukan hubungan fundamental.